Cervical cancer: is herpes simplex virus type II a cofactor?

Area of Science:

• Oncology
• Virology
• Epidemiology

Background:

• Cervical cancer is strongly linked to high-risk human papillomaviruses (HPV).
• Other sexually transmitted infections, like herpes simplex virus type 2 (HSV-2), are investigated as potential cofactors.
• HSV-2 is primarily sexually transmitted and has been anecdotally linked to increased cervical cancer incidence.

Purpose of the Study:

• To investigate the potential role of HSV-2 as a cofactor in cervical cancer development.
• To explore the mechanisms by which HSV-2 might influence cervical carcinogenesis.
• To reconcile conflicting epidemiological findings regarding HSV-2 and cervical cancer risk.

Main Methods:

• Review of independent epidemiological studies and molecular investigations.
• Analysis of viral genome transforming domains and their necessity for neoplastic transformation.
• Examination of HSV-induced cellular changes, including DNA synthesis, chromosomal alterations, and mutations.

Main Results:

• Epidemiological data on HSV-2 as a cervical cancer risk factor are conflicting.
• HSV-2 possesses transforming domains, but continuous viral gene expression is not essential for transformation.
• HSV infections induce unscheduled DNA synthesis, chromosomal amplifications, and mutations, suggesting a non-typical DNA tumor virus mechanism.

Conclusions:

• HSV-2 may act as a cofactor in a subset of cervical cancer cases.
• Persistent or abortive HSV-2 infections might induce permanent genetic alterations.
• These alterations could disrupt cervical epithelium differentiation, leading to abnormal proliferation and potentially cancer.